Canostix
Canostix aims to enable early cancer detection with a blood test based on photonics and pattern recognition. It uses photonics and machine learning to analyze blood samples for cancer signals. The approach upgrades commercially available hardware into screening machines and runs an evolving software solution for improved accuracy. The company targets a B2B healthcare setting, integrating with clinical labs and existing equipment to deliver scalable screening. The goal is affordable, population-wide cancer screening at the GP level to improve outcomes for the most common cancers.
Canostix
Canostix aims to enable early cancer detection with a blood test based on photonics and pattern recognition. It uses photonics and machine learning to analyze blood samples for cancer signals. The approach upgrades commercially available hardware into screening machines and runs an evolving software solution for improved accuracy. The company targets a B2B healthcare setting, integrating with clinical labs and existing equipment to deliver scalable screening. The goal is affordable, population-wide cancer screening at the GP level to improve outcomes for the most common cancers.